1. Ad Hoc Subcommittee of the American Academy of Neurology
AIDS Task Force. Research criteria for diagnosis of chronic inflammatory
demyelinating polyradiculoneuropathy (CIDP). Neurology
1991; 41:617-618.
2. Andreoli TE, Bennett JC, Carpenter CJ, Plum F, Smith LH. Hematological
Malignant Diseases. In: Cecil Essentials Of Medicine.
W.B. Saunders Company, 3rd ed., 1995; pp 393-397.
3. Bromberg MB, Feldman EL, Albers JW. Chronic inflammatory
demyelinating polyradiculoneuropathy: comparison of patients
with and without an associated monoclonal gammopathy. Neurology
1992; 42:1157-1163.
4. Eurelings M, Notermans NC, Van de Donk NW, Lokhorst HM.
Risk factors for hematological malignancy in polyneuropathy
associated with monoclonal gammopathy. Muscle Nerve 2001;
24:1295-1302.
5. Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating
polyneuropathy: clinical features and response to treatment
in 67 consecutive patients with and without a monoclonal
gammopathy. Neurology 1997; 48:321-328.
6. Henson RA, Urich H. Peripheral neuropathy associated with
malignant neoplasms. In: Henson RA, Urich H. Cancer and the
nervous system. Oxford: Blackwell Scientific. 1982; pp 368-
405.
7. Johnson PC, Rolak LA, Hamilton RH, Laguna F. Paraneoplastic
vasculitis of nerve: a remote effect of cancer. Ann Neurol 1979;
5:437-444.
8. Kuroda Y, Nakata H, Kakigi R, Oda K, Shibasaki H, Nakashiro
H. Human neurolymphomatosis by adult T-cell leukemia. Neurology
1989;39:144-146.
9. Lisak RP, Mitchell M, Zweiman B, Orrechio E, Asbury AK. Guillain-
Barre syndrome and Hodgkin’s disease: three cases with
immunological studies. Ann Neurol 1977; 1:72-78.
10. Mc Leod JG. Peripheral neuropathy associated with lymphomas,
leukemias, and polycythemia vera. In: Peripheral Neuropathy.
W.B. Saunders Company, 3rd ed., volume 2,1993; pp
1591-1598.
11. Monaco S, Bonetti B, Ferrari S, Moretto G, Nardelli E, Tedesco
F, et al. Complement-mediated demyelination in patients with
IgM monoclonal gammopathy and polyneuropathy. N Engl J
Med 1990; 322:649-652.
12. Öge AE, Parman Y. Polinöropatiler. A.E. Öge (ed); Nöroloji, ‹stanbul,
Nobel T›p Kitabevleri; 2004; ss. 591-625.
13. Said G. Chronic inflammatory demyelinative polyneuropathy. J
Neurol 2002; 249:245-253.
14. Sumi SM, Farrell DF, Knauss TA. Lymphoma and leukemia manifested
by steroid-responsive polyneuropathy. Arch Neurol
1983; 40:577-582.
15. Vallat JM, De Mascarel HA, Bordessoule D, Jauberteau MO,
Tabaraud F, Gelot A, Vallat AV. Non-Hodgkin malignant
lymphomas and peripheral neuropathies 13 cases. Brain 1995;
118:1233-1245.
16. Vallat JM, Leboutet MJ, Hugon J, Tabaraud F, Chartier JP, Boulesteix
JM. Demyelinating polyneuropathy associated with
cancer-a nerve biopsy study of eight cases. Clin Neuropathol
1988; 7:217.
17. Vital A. Paraproteinemic neuropathies. Brain Pathol 2001;
11:399-407.
18. Vital C, Vital A, Julien J, Rivel J, de Mascarel A, Vergier B, et al.
Peripheral neuropathies and lymphoma without monoclonal
gammopathy: a new classification. J Neurol 1990; 237:177-185.
Thank you for copying data from http://www.arastirmax.com